Terms: = Breast cancer AND HIST1H4I, MGC24116, 8294, P62805 AND Treatment
5 results:
1. Therapeutic Drug Monitoring of Endoxifen for Tamoxifen Precision Dosing: Feasible in Patients with Hormone-Sensitive breast cancer.
Braal CL; Jager A; Hoop EO; Westenberg JD; Lommen KMWT; de Bruijn P; Vastbinder MB; van Rossum-Schornagel QC; Thijs-Visser MF; van Alphen RJ; Struik LEM; Zuetenhorst HJM; Mathijssen RHJ; Koolen SLW
Clin Pharmacokinet; 2022 Apr; 61(4):527-537. PubMed ID: 34786650
[TBL] [Abstract] [Full Text] [Related]
2. Axillary lymph node and non-sentinel lymph node metastasis among the ACOSOG Z0011 eligible breast cancer patients with invasive ductal, invasive lobular, or other histological special types: a multi-institutional retrospective analysis.
Gao W; Zeng Y; Fei X; Chen X; Shen K
Breast Cancer Res Treat; 2020 Nov; 184(1):193-202. PubMed ID: 32740809
[TBL] [Abstract] [Full Text] [Related]
3. An accurate regression of developmental stages for breast cancer based on transcriptomic biomarkers.
Feng X; Zhang R; Liu M; Liu Q; Li F; Yan Z; Zhou F
Biomark Med; 2019 Jan; 13(1):5-15. PubMed ID: 30484698
[TBL] [Abstract] [Full Text] [Related]
4. Partial breast irradiation with CyberKnife after breast conserving surgery: a pilot study in early breast cancer.
Lozza L; Fariselli L; Sandri M; Rampa M; Pinzi V; De Santis MC; Franceschini M; Trecate G; Maugeri I; Fumagalli L; Bonfantini F; Bianchi G; Pignoli E; De Martin E; Agresti R
Radiat Oncol; 2018 Mar; 13(1):49. PubMed ID: 29566762
[TBL] [Abstract] [Full Text] [Related]
5. Trastuzumab in combination with weekly paclitaxel and carboplatin as neo-adjuvant treatment for HER2-positive breast cancer: The TRAIN-study.
van Ramshorst MS; van Werkhoven E; Mandjes IAM; Schot M; Wesseling J; Vrancken Peeters MTFD; Meerum Terwogt JM; Bos MEM; Oosterkamp HM; Rodenhuis S; Linn SC; Sonke GS
Eur J Cancer; 2017 Mar; 74():47-54. PubMed ID: 28335887
[TBL] [Abstract] [Full Text] [Related]
